4//SEC Filing
Terrillion Scott 4
Accession 0001209191-22-016431
CIK 0001346830other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:51 PM ET
Size
5.2 KB
Accession
0001209191-22-016431
Insider Transaction Report
Form 4
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Transactions
- Sale
Common Stock
2022-03-03$11.38/sh−1,787$20,336→ 103,986 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of performance-based RSUs reported in the Form 4 filed with the Securities and Exchange Commission on March 1, 2022, and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001706426
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:51 PM ET
- Size
- 5.2 KB